α1‐, α2‐ and β‐adrenoceptors in the urinary bladder, urethra and prostate
- 10 February 2006
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 147 (S2), S88-S119
- https://doi.org/10.1038/sj.bjp.0706619
Abstract
1 We have systematically reviewed the presence, functional responses and regulation of alpha(1)-, alpha(2)- and beta-adrenoceptors in the bladder, urethra and prostate, with special emphasis on human tissues and receptor subtypes. 2 Alpha(1)-adrenoceptors are only poorly expressed and play a limited functional role in the detrusor. Alpha(1)-adrenoceptors, particularly their alpha(1A)-subtype, show a more pronounced expression and promote contraction of the bladder neck, urethra and prostate to enhance bladder outlet resistance, particularly in elderly men with enlarged prostates. Alpha(1)-adrenoceptor agonists are important in the treatment of symptoms of benign prostatic hyperplasia, but their beneficial effects may involve receptors within and outside the prostate. 3 Alpha(2)-adrenoceptors, mainly their alpha(2A)-subtype, are expressed in bladder, urethra and prostate. They mediate pre-junctional inhibition of neurotransmitter release and also a weak contractile effect in the urethra of some species, but not humans. Their overall post-junctional function in the lower urinary tract remains largely unclear. 4 Beta-adrenoceptors mediate relaxation of smooth muscle in the bladder, urethra and prostate. The available tools have limited the unequivocal identification of receptor subtypes at the protein and functional levels, but it appears that the beta(3)- and beta(2)-subtypes are important in the human bladder and urethra, respectively. Beta(3)-adrenoceptor agonists are promising drug candidates for the treatment of the overactive bladder. 5 We propose that the overall function of adrenoceptors in the lower urinary tract is to promote urinary continence. Further elucidation of the functional roles of their subtypes will help a better understanding of voiding dysfunction and its treatment.Keywords
This publication has 172 references indexed in Scilit:
- Alpha1 adrenoceptor subtypes in human urinary bladder: Sex and regional comparisonLife Sciences, 2004
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- Modulation of the differentiation status of cultured prostatic smooth muscle cells by an ?1-adrenergic receptor antagonistThe Prostate, 1999
- Analysis of the relative biomechanical effects of α1 and α2 antagonists in modifying the compliance of the prostate and micturition parameters of the hormonally manipulated male ratNeurourology and Urodynamics, 1996
- NS-49, a novel α1a-adrenoceptor-selective agonist characterization using recombinant human α1-adrenoceptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Control of β3-adrenergic receptor gene expression in brown adipocytes in cultureMolecular and Cellular Endocrinology, 1995
- Identification of α1-adrenoceptor subtypes present in the human prostateLife Sciences, 1994
- Cloning, Expression and Characterization of Human α Adrenergic Receptors α1a, α1b and α1cBiochemical and Biophysical Research Communications, 1994
- Quantitative Analysis of Adrenergic Alpha-1 and Alpha-2 Receptors in Human Prostatic Urethral TissueBritish Journal of Urology, 1993
- Binding characteristics of naftopidil and α1-adrenoceptor antagonists to prostatic α-adrenoceptors in benign prostatic hypertrophyLife Sciences, 1992